G Brufman

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

C. Focan, S. M. Steinberg, M Blichert-Toft et al. · PubMed · 1998 · 2.2K citations

Medicine, Oncology, Pharmacotherapy +5

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

Olga Lyass, Beatrice Uziely, Rami Ben‐Yosef et al. · Cancer · 2000 · 388 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

The effect of tamoxifen on the endometrium

Beatrice Uziely, Abi Lewin, G Brufman et al. · Breast Cancer Research and Treatment · 1993 · 97 citations

Medicine, Gynecology, Obstetrics +10

Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer

G Brufman, E Colajori, N. Ghilezan et al. · Annals of Oncology · 1997 · 79 citations · Full text

Medicine, Oncology, Pharmacology +15

The Management of Pericardial Effusion in Cancer Patients

S Biran, G Brufman, Ehud Klein et al. · CHEST Journal · 1977 · 33 citations

Medicine, Cardiology, Oncology +10